Cost-Utility Analysis of Survival with Epoetin-Alfa versus Placebo in Stage IV Breast Cancer

Translated title of the contribution: Cost-Utility Analysis of Survival with Epoetin-Alfa versus Placebo in Stage IV Breast Cancer

C. Martin Silas, D.D. Gagnon, Lucy Zhang, Carsten Bokemeijer, M. van Marwijk Kooy, B.A. van Hout

Research output: Contribution to journal › Article › Academic › peer-review

Translated title of the contribution	Cost-Utility Analysis of Survival with Epoetin-Alfa versus Placebo in Stage IV Breast Cancer
Original language	Undefined/Unknown
Pages (from-to)	1153-1169
Number of pages	16
Journal	PharmacoEconomics
Volume	21
Issue number	16
Publication status	Published - 2003

Cite this

@article{d156f9fbe14e4dddaef0af11eafcece0,

title = "Cost-Utility Analysis of Survival with Epoetin-Alfa versus Placebo in Stage IV Breast Cancer",

author = "Silas, \{C. Martin\} and D.D. Gagnon and Lucy Zhang and Carsten Bokemeijer and \{van Marwijk Kooy\}, M. and \{van Hout\}, B.A.",

year = "2003",

language = "Undefined/Unknown",

volume = "21",

pages = "1153--1169",

journal = "PharmacoEconomics",

issn = "1170-7690",

publisher = "Adis",

number = "16",

}

TY - JOUR

T1 - Cost-Utility Analysis of Survival with Epoetin-Alfa versus Placebo in Stage IV Breast Cancer

AU - Silas, C. Martin

AU - Gagnon, D.D.

AU - Zhang, Lucy

AU - Bokemeijer, Carsten

AU - van Marwijk Kooy, M.

AU - van Hout, B.A.

PY - 2003

Y1 - 2003

M3 - Article

SN - 1170-7690

VL - 21

SP - 1153

EP - 1169

JO - PharmacoEconomics

JF - PharmacoEconomics

IS - 16

ER -